Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s 4D Molecular Therapeutics FDMT Stock Holding History

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Portfolio FDMT Stock Details FDMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-412,000	Closed	-$1.33M	–	1129
2025 Q1	$1.33M	Sell	412,000 -47,000	-10%	-$221K	﹤0.01%	698
2024 Q4	$2.56M	Hold	459,000	–	–	0.01%	635
2024 Q3	$4.96M	Sell	459,000 -247,000	-35%	-$4.1M	0.01%	486
2024 Q2	$14.8M	Buy	706,000 +65,000	+10%	+$1.63M	0.04%	234
2024 Q1	$20.4M	Buy	641,000 +586,500	+1,076%	+$15M	0.07%	180
2023 Q4	$1.1M	Sell	54,500 -294,200	-84%	-$3.87M	﹤0.01%	748
2023 Q3	$4.44M	Buy	348,700 +14,400	+4%	+$241K	0.02%	388
2023 Q2	$6.04M	Sell	334,300 -138,200	-29%	-$2.54M	0.03%	339
2023 Q1	$8.12M	Sell	472,500 -301,100	-39%	-$5.86M	0.04%	250
2022 Q4	$17.2M	Buy	+773,600	New	+$11.9M	0.08%	191

Other funds holding FDMT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's FDMT Position: Q2 2025 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of 4D Molecular Therapeutics (FDMT) in Q2 2025, closing a stake of 412,000 shares — an estimated $1.33M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in FDMT in Q4 2022 and held it in 10 quarters. The position peaked at $20.4M in Q1 2024. 120 funds tracked by Wall St. Rank hold FDMT as of Q2 2025.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining 4D Molecular Therapeutics position as of Q2 2025 after selling out during the quarter.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 412,000 4D Molecular Therapeutics shares in Q2 2025, an estimated $1.33M.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in 4D Molecular Therapeutics in Q4 2022 and held it in 10 quarters.
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 4D Molecular Therapeutics position peaked at $20.4M in Q1 2024.
120 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2025.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q2 2025, filed 13 Aug 2025.